Navigation Links
Benign eye tumors being treated

Researchers at the University of Texas feel that they may have found an effective treatment for a type of non-cancerous eye tumor that threatens clear vision.// Using photodynamic therapy, researchers successfully restored vision in three patients who were suffering from intraocular choroidal hemangiomas, which involved serious retinal detachments.

Intraocular choroidal hemangiomas are benign tumors, which can cause symptoms due to their location, growth, and the accumulation of fluid in the eye. Doctors generally don't treat the tumors unless the problems lead to vision loss or a detached retina.

In these cases, each of the patients was suffering from a tumor in one eye, and all suffered loss of vision and a detached retina. In the first case, a 60 year old man attempted reatment after experiencing decreased visual acuity in his right eye for two weeks. In the second case, a 40 year old man came to the clinic complaining of flickering lights and decreased visual acuity in his left eye. The third subject was a 65 year old man who had been initially diagnosed in 1995 and followed for the next 5 years, during which time he began to experience significantly worsening vision and an expanding central blind spot.

Researchers used photodynamic therapy to treat the detached retinas and shrink the tumors. Photodynamic therapy includes a light-sensitive dye that produces blood clots to terminate the growth of abnormal new blood vessels. In all three cases, the therapy resolved the detached retinas and shrunk the tumors beyond measurable size. Vision improved to 20/20 for the first two patients and to 20/200 for the third patient. After 10 months to 15 months of follow-up, none of the tumors had returned. Researchers conclude photodynamic therapy appears to be effective for the treatment of choroidal hemangioma.


'"/>




Page: 1

Related medicine news :

1. New Technique For Benign Breast Tumors
2. Another Treatment Option for Benign Tumors
3. ‘Benign’ MS May Not Be So Benin
4. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
5. Morphine may excite cancerous tumors
6. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
7. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Same molecule found in meat, milk, tumors
10. Women with borderline ovarian tumors can still preserve their fertility
11. Surgery to remove tumors in the spine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: